EnGene Appoints Ryan Daws as Chief Financial Officer

BOSTON and MONTREAL, Nov. 29, 2023 /PRNewswire/ - enGene Holdings Inc. , a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle...

Related Keywords

United States ,Canada ,Montreal ,Quebec ,Boston ,Massachusetts ,Canadian ,Derivatized Oligochitosan ,Jasond Hanson ,University Of South Carolina ,Gene Holdings Inc ,International Master Of Business Administration ,Nasdaq ,Forbion European Acquisition Corporation ,Business Administration ,Prior To Concert Pharmaceuticals ,Exchange Commission ,Head Of Business Development ,Nicolaus Co Inc ,Gene Holdings ,Ryan Daws ,Chief Financial Officer ,Chief Executive Officer ,Business Development ,Obsidian Therapeutics ,Managing Director ,Healthcare Investment Banking Group ,Concert Pharmaceuticals ,International Master ,Bacillus Calmette Gu ,Dually Derivatized Oligochitosan ,Private Securities Litigation Reform Act ,Registration Statement ,Markets ,